Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

3M Co ha un obiettivo di prezzo di consenso pari a $150.85, stabilito in base alle ultime valutazioni degli analisti di 20. Le ultime 3 valutazioni degli analisti sono state rilasciate da UBS, Morgan Stanley y Barclays il octubre 22, 2025. Con un obiettivo di prezzo medio di $176.67 tra le UBS, Morgan Stanley y Barclays, c'è un implicito 6.31% upside per 3M Co da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 10/22/2025 | 14.33% | UBS | $184 → $190 | Maintains | Buy | |||
| 10/22/2025 | -3.72% | Morgan Stanley | $130 → $160 | Upgrade | Underweight → Equal-Weight | |||
| 10/22/2025 | 8.32% | Barclays | $172 → $180 | Maintains | Overweight | |||
| 10/22/2025 | -21.77% | RBC Capital | $120 → $130 | Maintains | Underperform | |||
| 10/22/2025 | 10.12% | Wells Fargo | $176 → $183 | Maintains | Overweight | |||
| 10/15/2025 | 7.11% | JP Morgan | $175 → $178 | Maintains | Overweight | |||
| 10/09/2025 | 1.7% | Citigroup | $160 → $169 | Maintains | Neutral | |||
| 10/06/2025 | 5.91% | Wells Fargo | $170 → $176 | Maintains | Overweight | |||
| 07/21/2025 | 3.5% | Barclays | $170 → $172 | Maintains | Overweight | |||
| 07/09/2025 | 2.3% | Barclays | $164 → $170 | Maintains | Overweight | |||
| 07/01/2025 | 2.3% | Wells Fargo | $150 → $170 | Maintains | Overweight | |||
| 05/30/2025 | -3.72% | Citigroup | $141 → $160 | Maintains | Neutral | |||
| 05/16/2025 | 0.49% | JP Morgan | $140 → $167 | Maintains | Overweight | |||
| 04/23/2025 | -15.15% | Citigroup | $142 → $141 | Maintains | Neutral | |||
| 04/23/2025 | -39.82% | RBC Capital | $98 → $100 | Maintains | Underperform | |||
| 04/23/2025 | -1.31% | Barclays | $160 → $164 | Maintains | Overweight | |||
| 04/14/2025 | -14.55% | Citigroup | $152 → $142 | Maintains | Neutral | |||
| 04/10/2025 | -3.72% | Barclays | $165 → $160 | Maintains | Overweight | |||
| 04/08/2025 | -15.75% | JP Morgan | $165 → $140 | Maintains | Overweight | |||
| 03/06/2025 | 7.71% | B of A Securities | $175 → $179 | Maintains | Buy | |||
| 02/27/2025 | -42.23% | RBC Capital | $96 → $96 | Reiterates | Underperform → Underperform | |||
| 01/22/2025 | -42.23% | RBC Capital | $96 → $96 | Reiterates | Underperform → Underperform | |||
| 01/22/2025 | 5.31% | B of A Securities | $160 → $175 | Maintains | Buy | |||
| 01/22/2025 | -8.53% | Citigroup | $142 → $152 | Maintains | Neutral | |||
| 01/22/2025 | -0.71% | Barclays | $161 → $165 | Maintains | Overweight | |||
| 01/22/2025 | -0.71% | JP Morgan | $162 → $165 | Maintains | Overweight | |||
| 01/22/2025 | 2.3% | Wells Fargo | $140 → $170 | Upgrade | Equal-Weight → Overweight | |||
| 01/15/2025 | -2.52% | JP Morgan | $165 → $162 | Maintains | Overweight | |||
| 01/08/2025 | -3.12% | Barclays | $165 → $161 | Maintains | Overweight | |||
| 01/03/2025 | -42.23% | RBC Capital | $100 → $96 | Maintains | Underperform | |||
| 11/13/2024 | 10.72% | UBS | $130 → $184 | Upgrade | Neutral → Buy | |||
| 10/28/2024 | -0.71% | JP Morgan | $160 → $165 | Maintains | Overweight | |||
| 10/23/2024 | -39.82% | RBC Capital | $99 → $100 | Maintains | Underperform | |||
| 10/23/2024 | -3.72% | B of A Securities | $143 → $160 | Maintains | Buy | |||
| 10/23/2024 | -0.71% | Barclays | $160 → $165 | Maintains | Overweight | |||
| 10/22/2024 | 8.32% | Melius Research |  → $180 | Upgrade | Hold → Buy | |||
| 10/17/2024 | -12.14% | Mizuho | $105 → $146 | Maintains | Neutral | |||
| 10/07/2024 | -15.75% | Wells Fargo | $130 → $140 | Maintains | Equal-Weight | |||
| 10/02/2024 | -3.72% | Barclays | $145 → $160 | Maintains | Overweight | |||
| 09/06/2024 | -24.78% | Morgan Stanley |  → $125 | Initiates |  → Underweight | |||
| 07/31/2024 | -9.74% | Deutsche Bank | $110 → $150 | Upgrade | Hold → Buy | |||
| 07/30/2024 | -12.75% | Argus Research |  → $145 | Upgrade | Hold → Buy | |||
| 07/29/2024 | -19.97% | Citigroup | $100 → $133 | Maintains | Neutral | |||
| 07/29/2024 | -12.75% | Barclays | $120 → $145 | Maintains | Overweight | |||
| 07/29/2024 | -13.95% | B of A Securities | $120 → $143 | Maintains | Buy | |||
| 07/29/2024 | -42.83% | RBC Capital | $93 → $95 | Maintains | Underperform | |||
| 07/10/2024 | -27.79% | Barclays | $118 → $120 | Maintains | Overweight | |||
| 07/10/2024 | -33.81% | Wells Fargo | $100 → $110 | Maintains | Equal-Weight | |||
| 06/13/2024 | -24.78% | Wolfe Research |  → $125 | Upgrade | Peer Perform → Outperform | |||
| 06/07/2024 | -27.79% | B of A Securities | $105 → $120 | Upgrade | Neutral → Buy | |||
| 05/28/2024 | -28.99% | Barclays | $112 → $118 | Maintains | Overweight | |||
| 05/16/2024 | -15.75% | Vertical Research | $92 → $140 | Upgrade | Hold → Buy | |||
| 05/10/2024 | -30.8% | HSBC | $91.13 → $115 | Upgrade | Hold → Buy | |||
| 05/01/2024 | -39.82% | Citigroup | $98 → $100 | Maintains | Neutral | |||
| 05/01/2024 | -47.65% | RBC Capital | $78 → $87 | Maintains | Underperform | |||
| 05/01/2024 | -39.82% | UBS | $98 → $100 | Maintains | Neutral | |||
| 05/01/2024 | -33.2% | JP Morgan | $110 → $111 | Upgrade | Neutral → Overweight | |||
| 04/17/2024 | -33.81% | JP Morgan | $118 → $110 | Maintains | Neutral | |||
| 04/08/2024 | -41.03% | Citigroup | $95.31 → $98 | Maintains | Neutral | |||
| 04/02/2024 | -53.06% | RBC Capital | $84 → $78 | Maintains | Underperform | |||
| 04/02/2024 | -35.61% | Barclays | $126 → $107 | Maintains | Overweight | |||
| 04/02/2024 | -39.82% | B of A Securities | $110 → $100 | Maintains | Neutral | |||
| 03/27/2024 | -36.82% | Mizuho | $105 → $105 | Maintains | Neutral | |||
| 03/20/2024 | -49.45% | RBC Capital | $84 → $84 | Reiterates | Underperform → Underperform | |||
| 03/19/2024 | -24.18% | Barclays | $111 → $126 | Upgrade | Equal-Weight → Overweight | |||
| 03/11/2024 | -33.2% | Barclays | $110 → $111 | Maintains | Equal-Weight | |||
| 03/07/2024 | -49.45% | RBC Capital | $85 → $84 | Maintains | Underperform | |||
| 01/24/2024 | -47.65% | RBC Capital | $83 → $87 | Maintains | Underperform | |||
| 01/24/2024 | -36.82% | Mizuho | $120 → $105 | Maintains | Neutral | |||
| 01/24/2024 | -37.42% | Citigroup | $117 → $104 | Maintains | Neutral | |||
| 01/24/2024 | -36.82% | Wells Fargo | $112 → $105 | Maintains | Equal-Weight | |||
| 12/19/2023 | -32.6% | Wells Fargo | $100 → $112 | Maintains | Equal-Weight | |||
| 12/04/2023 | -35.61% | Barclays | $98 → $107 | Upgrade | Underweight → Equal-Weight | |||
| 10/25/2023 | -36.82% | JP Morgan | $104 → $105 | Maintains | Neutral | |||
| 10/25/2023 | -50.05% | RBC Capital | $85 → $83 | Maintains | Underperform | |||
| 10/25/2023 | -41.63% | Citigroup | $95 → $97 | Maintains | Neutral | |||
| 10/25/2023 | -41.03% | Barclays | $96 → $98 | Maintains | Underweight | |||
| 10/09/2023 | -42.83% | Citigroup | $111 → $95 | Maintains | Neutral | |||
| 09/15/2023 | -34.41% | HSBC |  → $109 | Initiates |  → Hold | |||
| 08/31/2023 | -32% | Morgan Stanley | $102 → $113 | Upgrade | Underweight → Equal-Weight | |||
| 08/29/2023 | -27.79% | Mizuho |  → $120 | Reiterates | Neutral → Neutral | |||
| 08/29/2023 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
| 07/26/2023 | -38.62% | Morgan Stanley | $100 → $102 | Maintains | Underweight | |||
| 07/26/2023 | -33.2% | Citigroup | $100 → $111 | Maintains | Neutral | |||
| 07/26/2023 | -39.82% | RBC Capital | $95 → $100 | Maintains | Underperform | |||
| 07/14/2023 | -39.82% | Morgan Stanley | $100 → $100 | Reiterates | Underweight → Underweight | |||
| 07/11/2023 | -33.81% | B of A Securities |  → $110 | Upgrade | Underperform → Neutral | |||
| 07/11/2023 | -4.32% | DA Davidson | $138 → $159 | Maintains | Buy | |||
| 07/11/2023 | -39.82% | Citigroup | $120 → $100 | Maintains | Neutral | |||
| 07/10/2023 | -39.82% | Wells Fargo | $110 → $100 | Maintains | Equal-Weight | |||
| 07/10/2023 | -44.04% | Barclays | $103 → $93 | Maintains | Underweight | |||
| 06/27/2023 | -39.82% | Morgan Stanley | $102 → $100 | Maintains | Underweight | |||
| 06/01/2023 | -42.83% | UBS | $115 → $95 | Maintains | Neutral | |||
| 05/22/2023 | -42.83% | RBC Capital |  → $95 | Reiterates | Underperform → Underperform | |||
| 04/26/2023 | -42.83% | RBC Capital | $89 → $95 | Maintains | Underperform | |||
| 04/26/2023 | -38.62% | Morgan Stanley | $103 → $102 | Maintains | Underweight | |||
| 04/19/2023 | -38.02% | Morgan Stanley | $110 → $103 | Maintains | Underweight | |||
| 04/13/2023 | -33.81% | Wells Fargo | $115 → $110 | Maintains | Equal-Weight | |||
| 04/06/2023 | -38.02% | Barclays | $105 → $103 | Maintains | Underweight | |||
| 03/30/2023 | -10.94% | RBC Capital | $143 → $148 | Maintains | Sector Perform | 
El último precio objetivo de 3M (NYSE:MMM) fue comunicado por UBS el octubre 22, 2025. La firma de analistas fijó un precio objetivo para $190.00 que espera MMM a rise dentro de 12 meses (un posible 14.71% upside). 31 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para 3M (NYSE:MMM) fue proporcionada por UBS, y 3M mantuvo su buy calificación.
La última revisión al alza de 3M Co se produjo en octubre 22, 2025, cuando Morgan Stanley elevó su precio objetivo a $160. Morgan Stanley anteriormente tenía an underweight para 3M Co.
No hay una última revisión a la baja para 3M.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de 3M, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de 3M se registró el octubre 22, 2025, por lo que la próxima calificación estará disponible en torno al octubre 22, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de 3M (MMM) fue un mantuvo con un precio objetivo de $184.00 a $190.00. El precio actual al que cotiza 3M (MMM) es de $165.64, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.